Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yukimasa Shiotsu

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 4, 2003
[Current screening for molecular target therapy of cancer]Yukimasa Shiotsu
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 12, 2010
[Steroid sulfatase inhibitor]Taisuke Nakata, Hiroyuki Ishida, Yukimasa Shiotsu
Current Pharmaceutical Design|August 28, 2012
Hsp90 inhibitors as anti-cancer agents, from basic discoveries to clinical developmentShiro Soga, Shiro Akinaga, Yukimasa Shiotsu
Current Cancer Drug Targets|October 8, 2003
Development of radicicol analoguesShiro Soga, Yukimasa Shiotsu, Shiro Akinaga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2010
New molecular and biological mechanism of antitumor activities of KW-2478, a novel nonansamycin heat shock protein 90 inhibitor, in multiple myeloma cellsTakayuki Nakashima, Toshihiko Ishii, Hisashi Tagaya, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 23, 2009
Expression level of enzymes related to in situ estrogen synthesis and clinicopathological parameters in breast cancer patientsMasayo Suzuki, Hiroyuki Ishida, Yukimasa Shiotsu, et al.
International Journal of Hematology|October 5, 2010
Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemiaAkane Tsujimura, Hitoshi Kiyoi, Yukimasa Shiotsu, et al.
Journal of Medicinal Chemistry|May 30, 2003
Synthesis and antitumor activity of novel O-carbamoylmethyloxime derivatives of radicicolYoji Ikuina, Nobuyoshi Amishiro, Mayumi Miyata, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 19, 2003
Steroid sulfatase and estrogen sulfotransferase in normal human tissue and breast carcinomaTakashi Suzuki, Yasuhiro Miki, Taisuke Nakata, et al.
Frontiers in Oncology|April 26, 2019
Detection of <i>ERBB2</i> (HER2) Gene Amplification Events in Cell-Free DNA and Response to Anti-HER2 Agents in a Large Asian Cancer Patient CohortJeeyun Lee, Aleksandra Franovic, Yukimasa Shiotsu, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 4, 2003
[Current screening for molecular target therapy of cancer]Yukimasa Shiotsu
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 12, 2010
[Steroid sulfatase inhibitor]Taisuke Nakata, Hiroyuki Ishida, Yukimasa Shiotsu
Current Pharmaceutical Design|August 28, 2012
Hsp90 inhibitors as anti-cancer agents, from basic discoveries to clinical developmentShiro Soga, Shiro Akinaga, Yukimasa Shiotsu
Current Cancer Drug Targets|October 8, 2003
Development of radicicol analoguesShiro Soga, Yukimasa Shiotsu, Shiro Akinaga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2010
New molecular and biological mechanism of antitumor activities of KW-2478, a novel nonansamycin heat shock protein 90 inhibitor, in multiple myeloma cellsTakayuki Nakashima, Toshihiko Ishii, Hisashi Tagaya, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 23, 2009
Expression level of enzymes related to in situ estrogen synthesis and clinicopathological parameters in breast cancer patientsMasayo Suzuki, Hiroyuki Ishida, Yukimasa Shiotsu, et al.
International Journal of Hematology|October 5, 2010
Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemiaAkane Tsujimura, Hitoshi Kiyoi, Yukimasa Shiotsu, et al.
Journal of Medicinal Chemistry|May 30, 2003
Synthesis and antitumor activity of novel O-carbamoylmethyloxime derivatives of radicicolYoji Ikuina, Nobuyoshi Amishiro, Mayumi Miyata, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 19, 2003
Steroid sulfatase and estrogen sulfotransferase in normal human tissue and breast carcinomaTakashi Suzuki, Yasuhiro Miki, Taisuke Nakata, et al.
Frontiers in Oncology|April 26, 2019
Detection of <i>ERBB2</i> (HER2) Gene Amplification Events in Cell-Free DNA and Response to Anti-HER2 Agents in a Large Asian Cancer Patient CohortJeeyun Lee, Aleksandra Franovic, Yukimasa Shiotsu, et al.
Pageof 3